Smoking Cessation: A Cardiologist's Patient Guide to Quitting for Your Heart

I have seen a lot of patients try to quit smoking. Some succeeded on the first attempt. Most did not. What I have learned from those encounters, and from the cardiovascular outcomes literature, is that quitting smoking is the single highest-impact intervention available to anyone with a heart. No statin, no blood pressure medication, no bypass operation delivers the same magnitude of risk reduction as stopping tobacco. If you are reading this as a smoker, or as the family member of one, this guide gives you a clear-eyed picture of what smoking does to the cardiovascular system, what the evidence says about the best ways to quit, what recovery actually looks like after the last cigarette, and how to build a plan that fits your life.

This isn’t a moral lecture or a guilt trip. Most smokers want to quit. Most are not weak or undisciplined. Nicotine is one of the most addictive substances in medicine, with dependence potential comparable to heroin or cocaine. Quitting is hard, and not because you’re failing. It’s hard because the brain has been chemically rewired by years of nicotine exposure. The science of what works is now clear, the medications have improved dramatically over the past 15 years, and most people who keep trying eventually succeed. The goal of this guide is to give you everything you need to make your next quit attempt the one that sticks.

What Does Smoking Actually Do to Your Heart?

Smoking damages the cardiovascular system in three main ways: it raises blood pressure and heart rate through nicotine’s effects on the nervous system, it lowers oxygen delivery by binding carbon monoxide to hemoglobin, and it accelerates atherosclerosis (the buildup of plaque in arteries) through endothelial damage, inflammation, and increased clot formation. The cumulative effect is roughly tripling the risk of heart attack, raising the risk of sudden cardiac death about 2.5-fold, and raising the risk of abdominal aortic aneurysm about fivefold.

What’s in the Smoke

Cigarette smoke contains about 7,000 chemicals. Dozens have direct cardiovascular toxicity. The three biggest offenders for the heart and blood vessels are nicotine, carbon monoxide, and oxidizing particulates.

Nicotine activates the sympathetic nervous system, raising heart rate and blood pressure with each puff. Over time, the repeated stimulation contributes to higher resting blood pressure and chronic vascular stress.

Carbon monoxide binds hemoglobin (the oxygen-carrying protein in red blood cells) more than 200 times more tightly than oxygen. A smoker’s blood carries less oxygen than a non-smoker’s. The heart muscle itself, which has high oxygen demand, runs in a chronically oxygen-poor state.

Oxidizing particulates damage the endothelium, the thin lining of blood vessels that regulates vascular tone, inflammation, and clotting. Endothelial damage is the first step in the cascade that leads to atherosclerosis.

How This Translates to Disease

Accelerated atherosclerosis: smokers develop coronary artery plaque earlier and more aggressively than non-smokers. A 30-year-old smoker has a vascular age closer to 40. By the 50s, many smokers have coronary disease that would otherwise not appear until the 70s or later.

Increased clot formation: smoking raises platelet reactivity and fibrinogen levels, so clots form more readily on damaged vessel walls. This is why smokers have higher rates of heart attacks (clots in coronary arteries), strokes (clots in brain arteries), and peripheral artery disease (clots and disease in leg arteries).

Higher overall cardiovascular death: smoking is responsible for about 1 in 4 cardiovascular deaths globally. The risk scales with packs per day and years smoked, but there is no safe level. Even smoking 1 cigarette per day carries roughly half the coronary heart disease risk of a 20-cigarette-per-day habit.

Specific Risks by Disease Category

Heart attack: smokers have nearly 3 times the risk compared to never-smokers, with an even higher risk in younger smokers. Smoking is especially dangerous in patients who already have coronary disease (more on this in a moment).

Stroke: smoking roughly doubles the risk of ischemic stroke and contributes to hemorrhagic stroke as well.

Sudden cardiac death: smoking raises the risk about 2.5-fold.

Abdominal aortic aneurysm: about a fivefold increased risk. Smoking is the single most important modifiable risk factor for this condition.

Peripheral artery disease: smokers have substantially higher rates of leg artery disease, which can progress to chronic leg pain, non-healing wounds, and amputation.

Heart failure: smoking contributes to coronary disease (the most common cause of heart failure) and may have additional direct effects on the heart muscle.

Atrial fibrillation: smoking modestly raises the risk and may worsen control of established AFib.

What Happens When You Quit?

Cardiovascular recovery starts within minutes of the last cigarette and compounds over decades. Within 20 minutes, heart rate and blood pressure begin to fall. Within 12 hours, carbon monoxide levels normalize. Within 1 year, coronary heart disease risk drops by about half. Within 5 to 15 years, stroke risk approaches the never-smoker level. For patients with existing cardiovascular disease, quitting reduces cardiovascular mortality by about 39 percent, a larger benefit than any single medication.

The First 24 Hours

Within 20 minutes of your last cigarette: heart rate and blood pressure begin to fall back toward your baseline.

Within 8 hours: carbon monoxide levels in your blood drop substantially.

Within 12 hours: carbon monoxide levels approach normal, and oxygen delivery to tissues improves.

Within 24 hours: heart attack risk has already begun to decline.

The First Few Weeks

Within 2 to 3 weeks: circulation improves measurably. Walking and exercise feel easier. Lung function begins to improve. Cough may temporarily worsen as cilia (the tiny hairs in the airways) regenerate and clear accumulated mucus.

Within 1 to 9 months: cough and shortness of breath improve substantially. Lung function continues to recover.

The First Year and Beyond

Within 1 year: coronary heart disease risk has dropped by about half compared to a continuing smoker.

Within 5 years: stroke risk approaches the never-smoker level for most quitters.

Within 10 to 15 years: coronary heart disease risk approaches the never-smoker level for light smokers. Heavy smokers (more than 20 pack-years) may need 20 to 25 years for full normalization.

The benefit continues to accumulate the longer you stay off tobacco. There’s no point at which quitting stops paying dividends.

Benefit for Patients With Existing Cardiovascular Disease

If you already have coronary disease, the benefit of quitting is even more striking. The 2022 Cochrane review of smoking cessation after cardiovascular events found a 39 percent reduction in cardiovascular mortality (hazard ratio 0.61) and a 43 percent reduction in major adverse cardiovascular events (hazard ratio 0.57) among quitters compared to continuing smokers. This is a larger mortality benefit than any medication we prescribe after a heart attack, including aspirin, statins, and beta-blockers. Stopping smoking is the single intervention I push hardest on every post-MI patient for exactly this reason.

Quitting at Different Ages

The earlier you quit, the larger the benefit, but the curve isn’t a cliff.

Quitting before age 40: eliminates roughly 90 percent of the excess death risk from smoking.

Quitting at age 45: adds roughly 6 years to life expectancy.

Quitting at age 55: adds roughly 4 years to life expectancy.

Quitting at age 65: adds about 2 years to life expectancy.

Even cessation after 65 buys meaningful time, and the quality-of-life benefits (better breathing, more energy, reduced cough) start immediately.

Why Is Quitting So Hard?

Nicotine is one of the most addictive substances known to medicine, with dependence potential similar to heroin or cocaine. It binds nicotinic receptors in the brain and triggers dopamine release in the brain’s reward center. With repeated exposure, the brain becomes physiologically dependent. Withdrawal starts within hours of the last cigarette and includes irritability, anxiety, difficulty concentrating, increased appetite, low mood, and intense craving. On top of the pharmacology, smoking is deeply embedded in daily routines (morning coffee, after meals, with stress, in social situations), and those cues continue to trigger craving long after the nicotine has cleared.

The Pharmacology

Nicotine binds to nicotinic acetylcholine receptors in the brain. These receptors normally respond to a neurotransmitter called acetylcholine that’s involved in many brain functions. When nicotine binds them, the brain releases dopamine in the reward center (the same pathway activated by other addictive drugs). The brain rapidly adapts to the chronic exposure: receptor density changes, the brain becomes more sensitive to nicotine, and over time the brain needs nicotine to feel normal.

Withdrawal

Within a few hours of the last cigarette, withdrawal symptoms begin. They typically include:

Irritability and short temper. Anxiety. Difficulty concentrating. Restlessness. Increased appetite. Sometimes low mood. Intense craving for cigarettes.

Symptoms peak in the first 3 to 5 days and gradually improve over 2 to 4 weeks. Some symptoms (occasional cravings, mild appetite changes) can last months.

The withdrawal isn’t dangerous in itself, but it’s deeply uncomfortable. That discomfort is what drives most relapses in the first week.

The Behavioral Layer

On top of the chemistry, smoking is deeply embedded in routine. People smoke with morning coffee, after meals, during stressful moments, with certain friends, at certain times of day. Those environmental cues continue to trigger craving long after the nicotine has cleared. Walking past your old smoke break spot 6 months into a quit attempt can produce a powerful craving even when the underlying physical dependence has resolved.

Why Willpower Alone Usually Fails

The relapse rate for unassisted quit attempts is about 95 percent. With a structured approach combining medication and behavioral support, one-year success rates triple or quadruple. The pharmacology is too entrenched and the behavioral cues too pervasive for most people to overcome with willpower alone. Using the medications doesn’t mean you lack willpower. It makes a hard task more achievable.

What Are the Evidence-Based Medications?

Three categories of medication are FDA-approved for smoking cessation: nicotine replacement therapy (NRT), varenicline (Chantix), and bupropion. The 2023 Cochrane network meta-analysis (319 randomized trials, more than 157,000 participants) found that varenicline and combination NRT approximately double placebo quit rates. Single-form NRT and bupropion increase quit rates by about 40 percent. Combining medication with behavioral counseling pushes the numbers higher still. Varenicline and combination NRT are first-line for patients with cardiovascular disease.

Nicotine Replacement Therapy (NRT)

NRT delivers nicotine without the 7,000 other combustion byproducts. The patch provides steady background nicotine to blunt withdrawal. Short-acting forms (gum, lozenge, inhaler, nasal spray) handle breakthrough cravings.

The most effective NRT strategy is combination therapy: a long-acting patch plus a short-acting rescue form. Combination NRT produces quit rates comparable to varenicline and substantially better than the patch alone.

NRT is safe in patients with stable cardiovascular disease, including those who have had a heart attack. The cardiovascular risk of continued smoking vastly exceeds any risk of NRT.

Dosing for the patch usually starts at 21 mg per day for heavy smokers (more than 10 cigarettes per day), 14 mg for moderate smokers, and 7 mg for light smokers, with gradual tapering over 8 to 12 weeks. Short-acting forms are used as needed for cravings.

Varenicline (Chantix)

Varenicline is a partial agonist at the alpha-4 beta-2 nicotinic receptor. It provides enough stimulation to reduce withdrawal while blocking the receptor from full activation if the patient does smoke. The blocking effect blunts the pleasure of a relapse cigarette.

The EAGLES trial showed varenicline produces biochemically confirmed continuous abstinence at weeks 9 through 24 of 21.8 percent, compared to 16.2 percent with bupropion, 15.7 percent with nicotine patch, and 9.4 percent with placebo. EAGLES also showed varenicline does not cause excess neuropsychiatric adverse events compared to placebo, and on the strength of those data the FDA removed varenicline’s black box warning for psychiatric events in 2016.

The EVITA trial, which randomized patients hospitalized with acute coronary syndrome, showed varenicline increased 52-week point-prevalence abstinence from 29 percent to 40 percent with no excess in major cardiovascular events.

Nausea is the most common side effect and usually improves after the first few weeks. Taking the medication with food often helps. Vivid dreams are also common and usually tolerable.

Standard dosing is 0.5 mg once daily for days 1 to 3, 0.5 mg twice daily for days 4 to 7, and 1 mg twice daily from day 8 through week 12. Treatment is sometimes extended to 24 weeks in patients who respond well.

Current AHA/ACC guidelines list varenicline or combination NRT as first-line pharmacotherapy for smokers with stable cardiovascular disease.

Bupropion

Bupropion is an atypical antidepressant that also reduces nicotine craving and withdrawal. It’s less effective than varenicline or combination NRT but is a reasonable choice for patients who also have depression, who can’t tolerate NRT, or who prefer an oral medication.

It should be avoided in patients with seizure disorders, active eating disorders, or recent alcohol or sedative withdrawal because it can lower the seizure threshold.

Standard dosing is 150 mg once daily for 3 days, then 150 mg twice daily starting 1 to 2 weeks before the quit date, continuing for 7 to 12 weeks.

Combination Therapy

Combining varenicline plus NRT, or combining bupropion plus NRT, is increasingly used in patients with strong dependence or prior failed attempts. The combinations are generally safe and may further improve quit rates.

Behavioral Support

Medication alone works, but medication plus counseling works better. Even brief physician counseling (a 5-minute discussion at a visit) improves quit rates. Quitline counseling is free in every US state and delivers meaningful benefit. Text-message programs and mobile apps like Smokefree.gov have randomized evidence behind them.

The National Cancer Institute quitline at 1-800-QUIT-NOW is the easiest entry point for most patients. It’s free, anonymous, and available in multiple languages.

What About E-Cigarettes?

E-cigarettes are complicated. They appear more effective than NRT for short-term cessation in some studies, but they aren’t FDA-approved for smoking cessation, long-term cardiovascular safety data are limited, and dual use (smoking and vaping at the same time) is worse for the heart than smoking alone. My approach is to steer patients toward FDA-approved therapies first. E-cigarettes are an option of last resort for patients who’ve failed all standard approaches.

What the Evidence Shows

Randomized trials and the 2025 Cochrane living systematic review now show that e-cigarettes increase quit rates by about 55 percent compared to NRT (relative risk 1.55). The Hajek 2019 NEJM trial reported 18 percent one-year abstinence on e-cigarettes versus 9.9 percent on NRT. So the short-term efficacy data are real.

The Concerns

E-cigarettes are not FDA-approved for smoking cessation.

Long-term cardiovascular safety data are limited. We have decades of data on cigarettes; we have a few years of data on vaping.

Vaping carries cardiovascular risks of its own: elevated blood pressure, endothelial dysfunction, platelet activation, and in some observational studies an increased rate of chest pain and arrhythmias.

The most concerning pattern is dual use (smoking and vaping at the same time). Pooled data show dual users have roughly 36 percent higher cardiovascular disease risk than exclusive combustible smokers (odds ratio 1.36). Adding vaping to smoking makes things worse, not better.

My Practical Approach

Try FDA-approved therapies (varenicline, combination NRT, bupropion) first. These are well-studied, well-tolerated, and have decades of safety data.

If those fail repeatedly and the patient is motivated to switch completely to e-cigarettes as a harm-reduction bridge, discuss the tradeoffs honestly and set a timeline for eventually tapering off the vape as well.

Never recommend starting e-cigarette use for someone who isn’t already a combustible smoker.

For teens and young adults who aren’t current smokers, the message is clear: don’t start vaping. The youth vaping epidemic has created a new pathway to nicotine dependence in a population that wouldn’t otherwise have been smokers.

What About the Weight Gain?

About 80 percent of people who quit smoking gain some weight, typically 7 to 13 pounds in the first year. Nicotine suppresses appetite and raises metabolic rate; both effects reverse after quitting. The data are clear that cardiovascular benefit of quitting is greater in people who gain weight than in people who don’t. Don’t let weight concerns stop you from quitting.

What the Numbers Look Like

Average post-quit weight gain in the first year: 7 to 13 pounds.

About 13 percent of quitters gain more than 22 pounds in the first year.

Weight gain levels off over time; most quitters don’t continue to gain after the first year.

Why Weight Gain Doesn’t Erase the Benefit

The 2018 NEJM analysis by Hu and colleagues, drawing on three large US cohorts, found something unexpected. Compared to continuing smokers, quitters who gained 5 to 10 kilograms of body weight had a 75 percent lower risk of cardiovascular death (hazard ratio 0.25), while quitters who gained no weight had a 31 percent lower risk (hazard ratio 0.69). Post-cessation weight gain does not erase the benefit of quitting. It’s associated with a larger survival benefit, not a smaller one.

Managing Post-Quit Weight Gain

If weight gain is a concern, several strategies help:

Plan ahead. Stock the kitchen with healthier snacks for the first few weeks. Have a regular eating schedule. Pre-portion snacks instead of eating from open packages.

Exercise. Even modest activity (walking 30 minutes a day) reduces post-quit weight gain and improves mood, which helps with cessation.

Sleep. Tobacco withdrawal disrupts sleep, and poor sleep drives more eating. Prioritize 7 to 9 hours.

Limit alcohol. Alcohol is a common relapse trigger and contributes to calorie intake.

Consider GLP-1 receptor agonists. In a 2023 randomized trial, dulaglutide produced about 3 kilograms less weight gain than placebo when added to varenicline and counseling. GLP-1 agonists don’t appear to improve abstinence rates themselves, but they address one of the most common patient-stated reasons for avoiding cessation, and they carry their own independent cardiovascular benefit. See our guide to GLP-1 cardioprotection for more.

How Should I Prepare for a Quit Attempt?

Set a specific quit date within the next 2 weeks. Start medication 5 to 7 days before that date (or on the date for NRT). Remove cigarettes and lighters from the home, car, and work. Tell family and friends. Plan for the first hard week with specific strategies for coffee, meals, driving, and social situations. Call the quitline. Build a list of cravings strategies and a plan for what to do if you slip.

Picking a Quit Date

Don’t wait for the “right time.” The right time never comes. Pick a date within the next 2 weeks that has at least one or two relatively low-stress days at the start. Avoid the night before a big presentation, a major holiday, or a family wedding, but don’t postpone for 6 months waiting for a perfect window.

Getting Medication Ready

Most medications work best when started before the quit date.

Varenicline: start 7 days before the quit date and titrate up. By the quit date, you’ll be at full dose and the medication will be working.

NRT patch: usually started on the quit day.

NRT short-acting forms (gum, lozenge, inhaler, nasal spray): have a supply on hand from the quit day.

Bupropion: start 1 to 2 weeks before the quit date.

Get the prescription filled before the quit date. Have the medication on the nightstand.

Clearing the Environment

Remove cigarettes, lighters, ashtrays, and any other smoking-related items from your home, car, and office. Don’t keep “just one pack in case.” Hidden cigarettes will find you in a moment of stress.

Wash clothing and clean spaces that smell of smoke. The smell can trigger cravings.

If you live with another smoker, talk about whether they’re willing to quit with you or at least not smoke in the house or car.

Building a Support Network

Tell family and friends you’re quitting and what date. Let them know how they can help (and not help, asking constantly “how’s the quit going” can backfire).

Call 1-800-QUIT-NOW. The quitline is free and confidential.

Consider a text-message support program like SmokefreeTXT.

Some patients benefit from in-person group programs or individual counseling.

Planning for the First Hard Week

Make a list of your smoking triggers: morning coffee, after meals, driving, stress at work, social drinking, certain people, certain places. Plan an alternative behavior for each one.

Morning coffee: switch to tea for a week, or drink your coffee in a different location, or pair it with breakfast.

After meals: get up immediately, take a 5-minute walk, brush your teeth.

Driving: clean the car, change the air freshener, plan a different route to avoid your usual smoking spots.

Stress: have a list of non-smoking stress responses ready (deep breathing, a 10-minute walk, calling a friend, a glass of cold water).

Social situations: tell your friends you’re quitting. Plan to be in non-smoking environments for the first 2 to 4 weeks if possible. Limit alcohol, which is a common relapse trigger.

Cravings Strategies

Most cravings last 3 to 5 minutes and pass on their own. Have a list of go-to strategies you can use in the moment:

The 4 D’s: Delay (tell yourself “5 more minutes”). Distract (do something with your hands or change your environment). Drink water. Deep breathe.

Use your short-acting NRT (gum, lozenge, inhaler) as needed for breakthrough cravings.

Call a support person.

Go for a short walk.

Brush your teeth.

Chew gum or eat a healthy snack.

What to Do If You Slip

Slips happen. One cigarette doesn’t have to mean a full relapse.

Don’t catastrophize. One slip isn’t failure.

Identify what triggered the slip and adjust your plan to address that trigger.

Get back on the medication and the quit plan immediately.

Call your support person or the quitline.

If you find yourself slipping repeatedly, consider whether you need to adjust medication (higher dose, combination therapy, longer duration) or add more behavioral support.

Setting Up Follow-Up

See your primary care doctor or cardiologist at 1 to 2 weeks into the quit. They can assess how you’re tolerating medication, troubleshoot side effects, and reinforce the plan.

See again at 1 month, 3 months, and 6 months. Continued follow-up substantially improves long-term success.

If you’ve quit before and relapsed, the new attempt benefits from a different combination of medication, longer duration, or additional behavioral support.

What Does the First Year of Quitting Actually Look Like?

The first week is the hardest. The first month is when most relapses happen. The first 3 months are when the brain’s reward circuitry is rewiring. The first year is when the cardiovascular benefits start to compound. Plan accordingly. Have your medication and support in place for at least the first 3 months. Have a relapse-prevention plan ready for the first year. Celebrate milestones.

Days 1 to 7

Withdrawal peaks. Cravings are intense and frequent. You may feel irritable, anxious, scattered. Your sleep may be disturbed. You may have headaches, dizziness, or unusual fatigue.

Strategies: stick to your plan. Use short-acting NRT for breakthrough cravings. Take walks. Drink water. Avoid high-risk situations. Don’t make important decisions or have difficult conversations if you can avoid them.

Week 2 to 4

Physical withdrawal symptoms gradually fade. Cravings become less frequent but can still be intense, especially when triggered. Sleep usually improves. Energy starts to return.

Strategies: keep using your medication. Build healthy routines (exercise, regular meals, regular sleep). Watch for the “relief relapse” (taking a single cigarette to relieve stress, which usually leads to full relapse).

Month 2 to 3

Most physical withdrawal is gone. Cravings are less frequent but can still occur, especially with triggers. Energy is substantially better. Lung function noticeably improves.

Strategies: stay on your medication for the full prescribed course (typically 12 weeks). Don’t taper off early. Keep your support system engaged. Be alert for the “I’ve got this” overconfidence that often precedes relapse.

Month 4 to 6

Most quitters feel substantially normal at this point. Cravings are infrequent but can hit hard when they do. Some triggers (a stressful event, a social situation) can produce intense brief cravings.

Strategies: complete the medication course. Continue with any counseling or quitline support. Watch for relapse triggers and have your strategies ready.

Month 7 to 12

Cravings are usually infrequent and brief. Most quitters feel they’ve established a non-smoking life.

Strategies: don’t get complacent. Watch for high-risk situations (stress, alcohol, social pressure). One cigarette can restart the cycle. Continue with periodic check-ins with your primary care doctor or cardiologist.

Beyond the First Year

You’re a non-smoker. Cravings become rare. The cardiovascular benefits continue to compound.

Strategies: occasional cravings can still occur, especially after years. Don’t underestimate them. The “just one” cigarette at a party or in a moment of stress is still the biggest risk.

Common Questions Patients Ask Me

How many quit attempts does it usually take?

The average successful quitter makes between 7 and 30 attempts before achieving lasting cessation. Each attempt teaches you something about what triggers relapse and what strategies help. Don’t view a relapse as failure; view it as data for the next attempt.

Can I just quit cold turkey without medication?

Yes, but the success rate is low (about 5 percent for unassisted attempts). With medication and behavioral support, success rates triple or quadruple. There’s no extra credit for doing it the hard way, and using medication doesn’t reduce the validity of your quit.

Is varenicline safe for someone with heart disease?

Yes. The EVITA trial studied varenicline directly in patients hospitalized with acute coronary syndrome and showed no excess in major cardiovascular events. Current AHA/ACC guidelines list varenicline as first-line for patients with stable cardiovascular disease.

Should I quit before I have surgery?

Yes, even a few weeks of cessation before surgery improves wound healing, reduces respiratory complications, and improves cardiovascular outcomes. The hospitalization for surgery can be a good launching point for permanent quitting, with NRT in the hospital and structured follow-up.

What if I’m pregnant?

Stop as soon as you can. NRT can be used in pregnancy if behavioral approaches haven’t worked, but the doses are typically lower and the duration shorter. Varenicline and bupropion are generally avoided in pregnancy. Discuss with your obstetric team.

What about nicotine pouches like Zyn?

Nicotine pouches deliver nicotine through the gums without combustion or vaping. They’re not FDA-approved for smoking cessation. Cardiovascular safety data are limited but probably better than smoking. As a harm-reduction step from cigarettes, they may be useful for some patients, but the goal should be eventual cessation of all nicotine.

Will my insurance cover cessation medications?

Most US insurance plans, including Medicare and Medicaid, cover smoking cessation medications and counseling. Coverage details vary; check with your specific plan. Many states also offer free NRT through the quitline.

How will I know if it’s working?

Quit success is binary in the sense that you either smoke or you don’t, but progress shows up in cravings (fewer, briefer, less intense), in energy levels, in lung function, in cough, and in the way food tastes. Track your day count; many quitters find that visible streaks motivate continued abstinence.

What if I have one cigarette? Is it all over?

No. One slip doesn’t have to mean full relapse. The key is to recognize the slip immediately, identify what triggered it, get back on your plan, and not catastrophize. Many successful long-term quitters had one or two slips along the way.

Can I drink coffee?

Yes, but be aware that coffee is a strong trigger for many smokers. You may want to change something about your coffee ritual (different cup, different location, different time) for the first few weeks. Some quitters switch to tea temporarily.

Can I drink alcohol?

Alcohol substantially raises the risk of relapse, especially in the first 3 months. Reducing or eliminating alcohol during the early quit period is one of the highest-yield strategies. Some quitters find that they can return to moderate drinking after 6 to 12 months; others find that alcohol is permanently a relapse risk.

What if I smoked for 40 years? Is it too late?

No. Even quitting at 65 adds about 2 years of life expectancy. Quitting at any age reduces cardiovascular event risk and improves quality of life (better breathing, more energy, less cough). The benefits start within hours of the last cigarette regardless of how long you smoked.

What about smokeless tobacco like chewing tobacco or snuff?

Smokeless tobacco delivers nicotine without combustion. Cardiovascular risks are lower than cigarettes but still real. The goal should be cessation of all nicotine, using NRT or varenicline as needed for the transition.

How Should I Plan My Day for the First Week of Quitting?

The first week needs structure. Schedule your morning, afternoon, and evening with specific non-smoking activities. Have your medications ready. Have your short-acting NRT in your pocket. Plan light exercise daily. Plan healthy snacks. Avoid high-risk situations. Reach out to your support network daily. Don’t make major decisions or have difficult conversations if you can avoid them.

Morning Routine

Take your varenicline or apply your patch first thing.

Eat breakfast. Don’t skip it; hunger triggers cravings.

If coffee is a strong trigger, switch to tea for a week or drink coffee in a different location.

Have short-acting NRT (gum, lozenge) in your pocket for the commute.

Workday Strategy

Take a 5-minute break every hour and do something other than smoke (walk to the water cooler, climb a flight of stairs, step outside without going to your old smoking spot).

Eat lunch away from your old smoking break locations.

Have a non-smoker buddy or call your support person mid-day.

Use short-acting NRT for cravings.

Evening Routine

Plan an activity for the after-work hours when many smokers smoke heavily. Walk, exercise, attend a non-smoking event.

Eat dinner. Get up immediately after. Brush teeth. Take a walk.

Avoid alcohol during the first 2 to 4 weeks.

If TV time was a smoking trigger, change the environment: different room, hands occupied with something (knitting, crossword, video game).

Sleep

Go to bed at a consistent time. Avoid screens for 30 to 60 minutes before bed (sleep disturbance is common in withdrawal).

If insomnia is severe, talk to your team. Brief use of sleep aids may be appropriate.

Daily Check-In

Call the quitline, text your support person, or use the SmokefreeTXT program.

Note your craving patterns: when and where they hit, what helped you get through them.

Track your day count.

Celebrate. Day 1 is hard. Day 7 is a real milestone. Day 30 is huge.

Reference Tables

Cardiovascular Recovery Timeline After Quitting

Comparison of Cessation Medications

Common Triggers and Strategies

A Final Note From Me

If you smoke and you want to stop, you have the most powerful single intervention in cardiovascular medicine available to you. Ask your doctor about varenicline or combination NRT. Call 1-800-QUIT-NOW. Pick a quit date within the next 2 weeks. Commit to the first hard week with specific strategies. Don’t try to do it on willpower alone; use the medications that work.

If you have coronary disease, prior heart attack, heart failure, peripheral artery disease, or an aortic aneurysm, the urgency is higher because your baseline risk is higher. The relative benefit of quitting is also the largest in your group. Stopping smoking after a heart attack reduces cardiovascular mortality by about 39 percent, more than any medication we prescribe.

If your partner, parent, or child smokes and you want to help them quit, know that pressure and shame don’t work. What works is making it easier for them to succeed when they’re ready: offering to attend the appointment where they get medication, removing smoking from the home, not smoking in their presence if you smoke yourself, celebrating every quit attempt whether or not it sticks. Most smokers want to quit. Most who don’t will die early from smoking. That’s the clearest risk-benefit calculation in preventive cardiology.

If you’ve tried to quit before and failed, you’re not unusual. The average successful quitter makes between 7 and 30 attempts. Each attempt teaches you something. The combination of medication, behavioral support, and a specific plan dramatically increases your odds compared to past attempts. The science of what works has improved substantially over the past 15 years.

The day to start is today. The second-best day is tomorrow. Pick a quit date within the next 2 weeks. Start your medication. Make your plan. Reach out for support.

If you have questions about smoking cessation in the context of your specific cardiovascular history, or you want help building a quit plan, our office can help. To get in touch, visit our practice website. For coordinated care, we work with the cardiovascular prevention team at San Diego Cardiovascular Associates.

References

1. US Surgeon General. The Health Consequences of Smoking, 50 Years of Progress. Atlanta, GA: US Department of Health and Human Services; 2014.

2. Wu AD, Lindson N, Hartmann-Boyce J, et al. “Smoking cessation for secondary prevention of cardiovascular disease.” Cochrane Database of Systematic Reviews. 2022.

3. Hackshaw A, Morris JK, Boniface S, Tang JL, Milenkovic D. “Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies.” BMJ. 2018;360:j5855.

4. Ding N, Sang Y, Chen J, et al. “Cigarette smoking, smoking cessation, and long-term risk of 3 major atherosclerotic diseases.” Journal of the American College of Cardiology. 2019.

5. Lindson N, Theodoulou A, Ordonez-Mena JM, et al. “Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.” Cochrane Database of Systematic Reviews. 2023.

6. Anthenelli RM, Benowitz NL, West R, et al. “Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES).” Lancet. 2016;387:2507-2520.

7. Eisenberg MJ, Windle SB, Roy N, et al. “Varenicline for smoking cessation in hospitalized patients with acute coronary syndrome (EVITA).” Circulation. 2016;133:21-30.

8. Barua RS, Rigotti NA, Benowitz NL, et al. “2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment.” Journal of the American College of Cardiology. 2018.

9. Virani SS, Newby LK, Arnold SV, et al. “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease.” Journal of the American College of Cardiology. 2023.

10. Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J. “Treatment of tobacco smoking: a review.” JAMA. 2022.

11. Lindson N, Livingstone-Banks J, Butler AR, et al. “Electronic cigarettes for smoking cessation.” Cochrane Database of Systematic Reviews. 2025.

12. Hu Y, Zong G, Liu G, et al. “Smoking cessation, weight change, type 2 diabetes, and mortality.” New England Journal of Medicine. 2018;379:623-632.

13. Jha P, Ramasundarahettige C, Landsman V, et al. “21st-century hazards of smoking and benefits of cessation in the United States.” New England Journal of Medicine. 2013;368:341-350.

Published on damianrasch.com. The above information was composed by Dr. Damian Rasch, drawing on individual insight and bolstered by digital research and writing assistance. The information is for educational purposes only and does not constitute medical advice.